Kuros Biosciences AG | WebDisclosure

PRESS RELEASE

published on 03/13/2024 at 07:00, 8 months 10 days ago

Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Kuros Biosciences AG reports significant growth in direct MagnetOs sales (163%) and total medical device sales (153%) in 2023. Positive EBITDA achieved. Plans for continued sales growth and profitability in 2024

Financial Results Sales Growth Kuros Biosciences AG MagnetOs Sales Medical Device Sales
BRIEF

published on 03/08/2024 at 07:05, 8 months 15 days ago

Kuros Biosciences dévoilera ses résultats financiers et ses développements pour l'exercice 2023

Résultats Annuels Kuros Biosciences Résultats Financiers 2023 Mise À Jour De L'entreprise Technologies De Greffe Osseuse
BRIEF

published on 03/08/2024 at 07:05, 8 months 15 days ago

Kuros Biosciences to Unveil 2023 Full Year Financial Results and Corporate Developments

Corporate Update Kuros Biosciences Bone Graft Technologies Annual Results Financial Results 2023
PRESS RELEASE

published on 03/08/2024 at 07:00, 8 months 15 days ago

Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Kuros Biosciences to report full-year financial results for 2023 and provide corporate update on March 13, 2024, with a conference call and webcast scheduled. Company overview and contact information included

Conference Call Corporate Update Kuros Biosciences Bone Graft Technologies Full-year Financial Results
PRESS RELEASE

published on 02/01/2024 at 07:00, 9 months 22 days ago

Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Kuros Biosciences to present at the CG 2024 Musculoskeletal Conference in San Francisco, discussing its MagnetOs portfolio of products for spinal fusion. CEO Chris Fair and other executives will attend, with a replay available for 90 days. Kuros Biosciences is a leader in next generation bone graft technologies

Kuros Biosciences CG 2024 Musculoskeletal Conference MagnetOs Spinal Fusion Bone Graft Technologies
PRESS RELEASE

published on 01/31/2024 at 07:00, 9 months 23 days ago

Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
Kuros Biosciences receives US FDA 510K clearance for MagnetOs Granules for interbody use and regulatory clearance in New Zealand. The company expands its international presence with an exclusive distribution agreement, extending the MagnetOs portfolio and bringing an advanced bone graft technology to the local medical community

FDA Clearance Kuros Biosciences MagnetOs Granules New Zealand Bone Graft
PRESS RELEASE

published on 10/12/2023 at 07:00, 1 year 1 month ago

Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
PRESS RELEASE

published on 08/09/2023 at 07:00, 1 year 3 months ago

Kuros Biosciences Reports Results for First Half 2023
PRESS RELEASE

published on 07/13/2023 at 19:29, 1 year 4 months ago

Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial
PRESS RELEASE

published on 05/08/2023 at 17:18, 1 year 6 months ago

Annual General Meeting of Kuros Biosciences approves all resolutions

Published on 11/22/2024 at 23:55, 23 hours 19 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 23 hours 44 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 4 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 5 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 5 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 6 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 7 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 1 day 5 hours ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 1 day 6 hours ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 1 day 8 hours ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 1 day 8 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 16 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News